Introducing the VITA CD4 test to fill the gap* in global health for Advanced HIV Diseases

VITA - the New Point-of-Care CD4 Counter on the Horizon

  • Improved functionality and data quality

  • Higher throughput

  • Reduced cartridge cost

  • State of art technology

VITA Point of Care CD4 Test Demo Video

Accesso VITA™ POC CD4 Test Demo Video

Simply mix approximately 20 uL whole blood sample in the dried reagent tube and add to the cartridge for 30 min incubation at room temperature; Measurement on the instrument takes about 1-2 min to get the results. No accurate sample volume pipetting and counting bead required.

Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production” — Medecins Sans Frontieres (Doctors Without Borders) May 11, 2023

With the crisis worsening, many HIV programmes in LMICs either have no access to CD4 testing or have access to only one novel, lateral-flow-based CD4 semi-quantitative assay that increasingly shows its limitations in terms of diagnostic performance and feasibility, particularly when used at the point of care as opposed to in controlled laboratory settings” - The Lancet - Global Health, 2025

For More Information About the VITA POC CD4 Test

Latest Results: comparing VITA Point of care CD4 test with flow cytometry standard test

Email: info@accessobio.com

Phone/text: +1 408-780-8187

Regulatory status may vary by region. Please consult your local distributor for specific details